HomeAPVO • NASDAQ
Aptevo Therapeutics Inc
add
$4.78
3.63%
After Hours:(0.42%)-0.020
$4.76
Closed: Jun 5, 4:08:47 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.41M | -4.93% |
Net income | -6.41M | 6.23% |
Net profit margin | — | — |
Earnings per share | -87.80 | 98.81% |
EBITDA | -6.42M | 6.66% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.14M | -79.13% |
Total assets | 8.34M | -52.68% |
Total liabilities | 9.82M | -14.84% |
Total equity | -1.47M | — |
Shares outstanding | 405.47K | — |
Price to book | -0.25 | — |
Return on assets | -135.38% | — |
Return on capital | -247.29% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.41M | 6.23% |
Cash from operations | -6.58M | 1.14% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -6.58M | 1.19% |
Free cash flow | -3.38M | 30.04% |
Previous close
$4.96
Day range
$4.78 - $5.18
Year range
$4.30 - $658.60
Market cap
3.24M USD
Avg Volume
276.80K
P/E ratio
-
Dividend yield
-
About
Founded
2016
Headquarters
Website
Employees
37
